Diana Martin - Concepedia

Author

Diana Martin

New Zealand Institute for Public Health and Forensic Science

Also Known As

D MARTIN, D Martin, D R Martin, D. MARTIN, D. Martin, D. R. MARTIN, D. R. Martin, D.R. Martin, DIANA R. MARTIN, David E. Martin

Publications

Citations

H-Index

Concepts

All Affiliations

New Zealand Institute for Public Health and Forensic Science University of Auckland Ministry of Health Novartis (Italy)Norwegian Institute of Public Health

About

Diana Martin is an author at New Zealand Institute for Public Health and Forensic Science specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	30	2K
2	Health Sciences	9	9	688
3	Public Health	7	7	383
4	Biochemistry	2	2	52
5	Natural Sciences	1	1	41

Diana Martin

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease James M. Musser, Vivek Kapur, Jenny Szeto, Infection and Immunity Genetic DiversityPathogenic MicrobiologyMedicineGeneticsPathogenesis	1995	231
<i>emm</i> Typing and Validation of Provisional M Types for Group A Streptococci1 Richard R. Facklam, Bernard Beall, Androulla Efstratiou, Emerging infectious diseases	1999	197
Neisseria meningitidis group B correlates of protection and assay standardization—International Meeting Report Emory University, Atlanta, Georgia, United States, 16–17 March 2005 Ray Borrow, G M Carlone, Nancy E. Rosenstein, Vaccine VaccinationMedical MicrobiologyHealth SciencesPathogen DetectionClinical Infectious Disease	2006	194
Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B<i>Neisseria meningitidis</i> Ellen Murphy, Lubomira Andrew, Kwok‐Leung Lee, The Journal of Infectious Diseases	2009	191
Extension of the Lancefield Classification for Group A Streptococci by Addition of 22 New M Protein Gene Sequence Types from Clinical Isolates: emm103 to emm124 R. F. Facklam, Diana Martin, L. Marguerite, Clinical Infectious Diseases Molecular EpidemiologyPathologyClinical IsolatesDrug ResistanceMedical Microbiology	2002	174
New Zealand Epidemic of Meningococcal Disease Identified by a Strain with Phenotype B:4:P1.4 Diana Martin, Susan J. Walker, Michael G. Baker, The Journal of Infectious Diseases New Zealand EpidemicPathogenic MicrobiologyPathogen DetectionMedical MicrobiologyEpidemic Strain B:4	1998	149
Serotype Identification of Group B Streptococci by PCR and Sequencing Fanrong Kong, Sonia Gowan, Diana Martin, Journal of Clinical Microbiology	2002	149
The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB Diana Martin, N. Ruijne, Lisa McCallum, Clinical and Vaccine Immunology Vr2 EpitopeImmunologyReverse VaccinologyVaccine TargetVaccine Surveillance	2006	103
Once-daily amoxicillin versus twice-daily penicillin V in group A -haemolytic streptococcal pharyngitis Diana Lennon, Emily Farrell, Diana Martin, Archives of Disease in Childhood	2008	99
Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci Sumalee Pruksakorn, Evelyn R. Brandt, Michael F. Good, The Lancet VaccinationReverse VaccinologyVaccine DevelopmentVaccine ResearchMedicine	1994	98

Page 1